Elizabeth Arden (Nasdaq: RDEN) reported earnings on Jan. 31. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q2), Elizabeth Arden missed estimates on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue grew and GAAP earnings per share increased.

Gross margins were steady, operating margins shrank, net margins dropped.

Revenue details
Elizabeth Arden booked revenue of $467.9 million. The eight analysts polled by S&P Capital IQ expected revenue of $492.6 million on the same basis. GAAP reported sales were 8.8% higher than the prior-year quarter's $429.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.58. The eight earnings estimates compiled by S&P Capital IQ anticipated $1.64 per share. GAAP EPS of $1.47 for Q2 were 3.5% higher than the prior-year quarter's $1.42 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 50.9%, about the same as the prior-year quarter. Operating margin was 13.6%, 80 basis points worse than the prior-year quarter. Net margin was 9.6%, 30 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $276.1 million. On the bottom line, the average EPS estimate is $0.18.

Next year's average estimate for revenue is $1.42 billion. The average EPS estimate is $2.66.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 72 members out of 94 rating the stock outperform, and 22 members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 28 give Elizabeth Arden a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Elizabeth Arden is outperform, with an average price target of $53.50.

Looking for alternatives to Elizabeth Arden? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.